Skip to main content
Free trial

Analyze this stock with AI

Ask AI to research recent events and build a visual report.

Tell your AI:

“Help me set up FinLab and analyze HR Healthcare Realty Trust Incorporated: https://finlab.finance/en/setup?stock=HR”

Run AI in browser

HR

Healthcare Realty Trust Incorporated Real Estate As of 2026-06-18
Quality Above avg
Valuation Cheaper
Risk Moderate
Active signals Active 52-week adjusted-price high
19.79 Close (USD)
+13.74% 60-day
  • Quality is above average. Operating margin sits near the 55th percentile. TTM ROE is about -4.5%.
  • Valuation is cheaper than most peers. TTM P/E is in the 8th percentile, lower than most liquid US common stocks.
  • Recent volatility is moderate. 60-day annualized volatility is near the 41th percentile. Average 20-day dollar volume is about $88.5M.
  • Signals are active now. 52-week adjusted-price high currently holds; the tables below show what followed in this stock’s own history.

Factor profile

Factor radar Good Valuation
64
ValuationQualityGrowthMomentumRisk / liquidity

Valuation

Indicators in this group are ranked by market percentile; lower valuation and volatility are better.

64 Good
TTM P/E -33.99
Cheap
Price / book 1.55
Pricey
Free-cash-flow yield (%) 2.04
Good

Historical evidence

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

52-week adjusted-price high

Active

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

12 historical occurrences (since 2017-06-26)
Average forward return after 52-week adjusted-price high。20-day: Win 41.7%, Sample 12, Median -0.82%, Excess -3.84%, Beat mkt rate 16.7%；60-day: Win 27.3%, Sample 11, Median -3.64%, Excess -7.37%, Beat mkt rate 18.2%；120-day: Win 27.3%, Sample 11, Median -5.51%, Excess -10.22%, Beat mkt rate 0%

120 days after: historical avg -5.54%

20-day -1.35%
60-day -3.68%
120-day -5.54%
20-day
60-day
120-day
Win
41.7%
27.3%
27.3%
Sample
12
11
11
Median
-0.82%
-3.64%
-5.51%
Excess
-3.84%
-7.37%
-10.22%
Beat mkt rate
16.7%
18.2%
0%

Over 11 occurrences, 120-day forward avg declined 5.54%, lagged the market by 10.22 pts; win rate 27.3%.

Valuation regime and forward returns

Daily TTM P/E is converted into an expanding own-history percentile, then grouped into five valuation regimes. Forward returns use adjusted prices over the next 240 trading days.

PE percentile bandSample days240-day avg returnMedianWin rateAvg excess (vs index)
0-20 17Insufficient data
20-40 You are here169-29.5% -30.9% 0% -18.4%
40-60 129-13.2% -12% 13.2% -11.6%
60-80 23Insufficient data
80-100 237+3.2% +4.2% 75.9% -29.7%

Quarterly EPS is aligned by SEC filing date before it is forward-filled to daily prices. The expanding percentile uses only information available up to each day.

Current TTM P/E is about 65.50, placing it in the 35.1 own-history percentile, inside the 20-40 bucket.

Valuation × momentum analogs

Each historical day is grouped by own-history P/E tercile and 60-day momentum direction, then tested for the next 120-trading-day adjusted return.

Valuation
Momentum
Cheap (own-history bottom third)
Middle
Expensive (own-history top third)
60-day momentum up
-21.3%
Win rate 8.6% Excess -13.8%
35d
-4.8%
Win rate 30.9% Excess -6.5%
136d
-2.7%
Win rate 55.4% Excess -18.2%
112d
60-day momentum down
-15.2%
Win rate 10.6% Excess -12.5%
216d
Now
0%
Win rate 62.5% Excess -7.3%
48d
+3.8%
Win rate 79.1% Excess -15.2%
148d

Currently in “Middle × 60-day momentum down”: across 48 historical days, 120-day forward avg declined 0%, win rate 62.5%, lagged the market by 7.3%.

Days = trading days in this bucket; returns use adjusted prices, ex-costs. 60-day momentum: direction of this stock's price over the past 60 trading days.

Market-wide momentum baseline

Across 94,737 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.40%, a 58.3% positive-return rate, and +3.10 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

Top-quintile 6-month momentum

Pending

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

6 times historically; 60-day forward avg -0.43%, win rate 66.7%, beating the market by -6.08 pts on average.

Filed revenue acceleration

Pending

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

5 times historically; 60-day forward avg -2.55%, win rate 40%, beating the market by -7.85 pts on average.

EPS surprise beat

Pending

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

Free trial

Analyze this stock with AI

Ask AI to research recent events and build a visual report.

Tell your AI:

“Help me set up FinLab and analyze HR Healthcare Realty Trust Incorporated: https://finlab.finance/en/setup?stock=HR”

Run AI in browser

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.